Reconditioned Iridex P3 Transscleral 810nm MicroPulse Laser

Call for Price

Versatile and Non-Incisional Glaucoma Treatment With MicroPulse® Transscleral Laser Therapy

  • A success rate of 60% to 80%1-17
  • Achieves IOP reduction of 30% to 45%1, 3, 6, 9-15, 17, 18
  • Durability of up to 72 months with 3 retreatments19
  • Over 120,000 patients treated in 60 countries
  • Leaves future treatment options open
  ... people are viewing this right now

  Share
Categories: ,

Product Description

A cost-effective combination of safety, efficacy, durability and repeatability in a non-incisional approach to glaucoma care. MicroPulse Transscleral Laser Therapy via the MicroPulse P3® Device offers you and your patients a therapy which can be introduced prior to, in conjunction with and following all other available glaucoma treatment options, and the ability to treat at several different time points throughout the course of the disease.

  • A success rate of 60% to 80%1-17
  • Leaves future treatment options open
  • Achieves IOP reduction of 30% to 45%1, 3, 6, 9-15, 17, 18
  • Durability of up to 72 months with 3 retreatments19
  • Used in 38 of the 39 best hospitals in the United States*
  • Reduction in drug burden in eye drops and oral medications1-4, 6-13, 18
  • Revised probe now available with improved ease of use, visualization, fit, and coupling
  • Limited amount of immediate follow-up
  • Patient downtime is significantly low
  • Low investment for high utility
  • Economic savings to patients
  • Covered under CPT 66710 in the U.S.A.**
Condition

Pre-Owned

My Cart
Close Wishlist
Close Recently Viewed
Categories

Stay Up to Date

Sign up!

to receive news and promotions

FREE SHIPPING IS ONLY AVAILABLE FOR ONLINE ORDERS IN THE CONTINENTAL UNITED STATES. CERTAIN EXCLUSIONS APPLY.

Exclusions include, but are not limited, to the following products: